4//SEC Filing
DERMA SCIENCES, INC. 4
Accession 0001144204-17-009673
CIK 0000892160operating
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 7:22 PM ET
Size
15.7 KB
Accession
0001144204-17-009673
Insider Transaction Report
Form 4
YETTER JOHN E
Vice President & CFO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2017-02-10−9,375→ 0 totalExercise: $6.40From: 2007-03-01Exp: 2017-02-22→ Common Stock (9,375 underlying) - Tax Payment
Common Stock
2017-02-10$7.00/sh−8,571$59,997→ 58,823 total - Award
Common Stock
2017-02-14+7,100→ 65,923 total - Tax Payment
Common Stock
2017-02-14$7.00/sh−2,637$18,459→ 63,286 total - Award
Stock Option (right to buy)
2017-02-14−21,200→ 21,200 totalExercise: $3.30From: 2017-02-14Exp: 2027-02-14→ Common Stock (21,200 underlying) - Exercise/Conversion
Common Stock
2017-02-10$6.40/sh+9,375$60,000→ 67,394 total
Footnotes (6)
- [F1]Shares delivered in connection with the cashless exercise of 9,375 options, previously granted pursuant to the issuer's stock option plan, at an exercise price of $6.40, as reported herein.
- [F2]The shares of common stock reported herein represent restricted stock units issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on March 2, 2016, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2016, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2016 were met, resulting in the vesting of 7,100 restricted stock units.
- [F3]Shares withheld in connection with the vesting of 7,100 restricted stock units, previously granted pursuant to the issuer's equity incentive plan, at a price of $7.00, as reported herein.
- [F4]A total of 75,000 of the options were granted pursuant to the issuer's stock option plan on March 1, 2007. Options for 25% of the shares vested immediately and options for the remaining shares vested at the rate of 25% per year starting on February 22, 2008. The revised total of 9,375 options reflects the issuer's 1-for-8 reverse split effective January 1, 2010.
- [F5]The options were originally granted in consideration of the reporting person's services to the issuer and without payment of cash.
- [F6]The options reported herein were issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on March 2, 2016, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2016, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2016 were met, resulting in the vesting of 21,200 options.
Documents
Issuer
DERMA SCIENCES, INC.
CIK 0000892160
Entity typeoperating
IncorporatedPA
Related Parties
1- filerCIK 0000892160
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 7:22 PM ET
- Size
- 15.7 KB